Post-Transplant Cyclophosphamide (PTCY) as Sole GVHD Prophylaxis is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anaemia Using Matched Sibling Donors

• Post-transplant cyclophosphamide feasible in sibling donor transplants for SAA• Low incidence of acute and chronic GVHD• Low incidence of GVHD compared to cyclosporine and methotrexate• High incidence of viral infections seen
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research